News

The contract is in line with EEC’s strategy to attract international pharma companies to further boost the domestic pharmaceutical cluster. Pfizer will provide the latest technologies for manufacturing

Tbolt line of dietary supplements, including V-Edge, S-Drive and E-Drive, delivers a high-potency energy shot with up to a six-hour effect. E-Drive comprises vitamin B12 supplement with green

The collaboration will enable both the companies to provide specialized preclinical and early clinical development services in the neuroscience domain to their combined customer base. JSW Lifesciences CEO

The Professional Intelligent Charge Capture solution can lower potential professional revenue loss, compliance overhead and lack of billing process transparency. The software is deployed to physician-users in groups

Epodure, a long-acting protein therapy product, helps deliver erythropoietin for many months from a single administration and has demonstrated elevation and stabilization of hemoglobin levels in anemic patients

The research will be led by Robert Dworkin, a professor in the Department of Anesthesiology and the Center for Human Experimental Therapeutics at the Medical Center. Dworkin will

Earlier, the Toronto manufacturing plant was inspected and approved by Health Canada. The manufacturing facility manufactures oral solid dosage forms including controlled-release and targeted-release tablets, spheres, beads and

R-Tech Ueno will use Albucult as a major component in its new therapy to treat severe and moderate dry eye conditions. Albucult is believed to confer many advantages

As per the deal, Gilead will be responsible for the formulation, manufacturing, registration, distribution and commercialisation of the single-tablet regimen worldwide, while Tibotec will co-detail the single-tablet regimen